What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a ...

Commerce Secretary Howard Lutnick originally stated the investigation should be completed by mid-June. However, a new report from Reuters says that any official announcement on tariffs is still weeks ...

Novo Nordisk (NYSE: NVO) is quite the divisive stock among both investors and analysts these days. Although its high-profile ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

President Trump has secretly signed a directive to the Pentagon to begin using military force against certain Latin American drug cartels that his administration has deemed terrorist organizations,” ...

As pharma drug pricing debates heat up, the 340B program faces mounting challenges from outdated regulations, duplicate ...

Tonix Pharmaceuticals Holding shares have surged 62% since my Buy call, driven by optimism for Tonmya’s FDA decision. Click ...

Governor Katie Hobbs (D-Ariz.) signed an executive order last week to lower the cost of prescription drugs for Arizona ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.